Press Releases

Internationally recognized tobacco experts, Richard O’Connor, PhD, (left) and Maciej Goniewicz, PhD, PharmD, are leading the WNY Center for Research on Flavored Tobacco Products at Roswell Park.

Roswell Park and URMC To Create $19 Million Research Program Focused on Flavored Tobacco

Thursday, September 20, 2018
The expertise of two regional research teams has earned a federal grant of nearly $20 million to create the nation’s first program dedicated to the study of flavored tobacco.

New Immunotherapy Approach Found in “Superagonist” Interleukin-15 Complex

Roswell Park clinical trial identifies small but critical protein involved in anticancer immune response
Wednesday, September 12, 2018
A recent development shows that the immune response to cancer can be further enhanced using cytokines, small proteins that act as chemical messengers transporting information between different types of immune cells. A clinical trial led by Marc Ernstoff, MD, the Katherine Anne Gioia Chair of Medicine at Roswell Park Comprehensive Cancer Center, found that a drug complex containing one of these cytokines, interleukin-15 (IL-15), is both safe and well tolerated in patients with advanced solid tumors. The findings have been published in Clinical Cancer Research, a journal of the American Association for Cancer Research (AACR).

Adolescent Users of Juul, Other E-Cigarette Pods Exposed to Nearly As Much Nicotine as Smokers, Study Shows

New generation of vape products contain high concentrations of nicotine salts, which are more readily absorbed
Friday, September 7, 2018
A new study on use of electronic cigarettes among adolescents reports striking findings: that young users of newer “pod” e-cigarette devices are absorbing nicotine at levels approaching nicotine exposure from traditional combustible cigarettes. The research, a collaboration between scientists at Roswell Park Comprehensive Cancer Center and pediatricians from Stony Brook Children’s Hospital, also reveals that Juul and similar products contain high concentrations of a modified, salt form of nicotine, which is more readily absorbed upon inhalation.

Roswell Park Team Identifies Possible Cause of Resistance to Prostate Cancer Treatment

Thursday, September 6, 2018
A collaborative research team has linked the development of castration-resistant prostate cancer and resistance to treatment to a lack of androgen receptor expression in prostate cancer cells, identifying a new therapeutic target for one of the deadliest forms of cancer among men. Results of this research, which was led by scientists at Roswell Park Comprehensive Cancer Center, were published today in the journal Nature Communications.

Director of Pastoral Care at Roswell Park Elected to Board of National Association of Catholic Chaplains

Thursday, September 6, 2018

BUFFALO, N.Y. —The Director of Pastoral Care at Roswell Park, Beth Lenegan, PhD, has been elected to the Board of Directors of the National Association of Catholic Chaplains (NACC).

Roswell Park Approach to Assessing Kidney Tumors May Spare Some Patients Surgery

Tuesday, August 28, 2018
A research team from Roswell Park Comprehensive Cancer Center has discovered a way to use computed tomography (CT) imaging to assess kidney tumors that test positive for the biomarker CD117 and accurately determine — before surgery — whether the tumor is benign or malignant.

Roswell Park Breast Cancer Program Recognized for its High Standard of Care for Patients

Friday, August 24, 2018
Roswell Park Comprehensive Cancer Center has been recognized for its excellence in caring for patients in its multidisciplinary Breast Center. The National Accreditation Program for Breast Centers (NAPBC) reaccredited Roswell Park for three years.

Roswell Park Among Top 3 Percent of Cancer Hospitals Nationwide

Tuesday, August 14, 2018
Roswell Park Comprehensive Cancer Center ranks among the top 3% of cancer centers nationwide, as assessed by U.S. News & World Report. The Buffalo-based center moved up three spots, to 30, on the media outlet’s annual list of 50 Best Hospitals for cancer and was also recognized as high-performing within two subspecialties: colon cancer surgery and lung cancer surgery. One of only five New York State centers to make the top 50, Roswell Park once again stands as the only facility in all of Western and Central New York to be named a Best Hospital for cancer.

Local High School Students Explore Diverse Healthcare Field at Roswell Park

Monday, August 13, 2018

BUFFALO, N.Y. — Sixty-two local high school students participated in a unique career development program at Roswell Park Comprehensive Cancer Center this summer.

Roswell Park Names New Director of Technology Transfer and Commercial Development

Tuesday, August 7, 2018
Patrick Emmerling, PhD, MBA, CLP, has been promoted to Director of Technology Transfer and Commercial Development at Roswell Park Comprehensive Cancer Center. As leader of the department dedicated to supporting Roswell Park inventors and maximizing the impact of their work, he will collaborate with researchers and other colleagues to assess market opportunities, secure intellectual property protection, negotiate partnering and licensing agreements and assist in commercializing Roswell Park innovations. 

Nationally Renowned Scientist Named Castellani Family Chair of Dermatology at Roswell Park

Monday, August 6, 2018
Oscar Colegio, MD, PhD, has been appointed as the Lawrence P. & Joan Castellani Family Endowed Chair in Dermatology at Roswell Park Comprehensive Cancer Center. Prior to this, he served as Associate Professor of Dermatology, Pathology and Surgery (Transplant) at Yale University.

Empire State Ride Raises $660,000 for Cancer Research at Roswell Park

Saturday, August 4, 2018
A group of 137 cyclists marked the end of their 500+ mile journey across New York State by crossing the Empire State Ride finish line in Niagara Falls, USA.